首页> 美国卫生研究院文献>other >A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffuse Large B-Cell Lymphoma

【2h】

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffuse Large B-Cell Lymphoma

机译：高/中危弥漫性大B细胞淋巴瘤患者标准化疗后来那度胺或来那度胺和利妥昔单抗作为维持治疗的II期随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 other
作者
Nishitha M. Reddy; John P. Greer; David S. Morgan; Heidi Chen; Steven I. Park; Kristy L. Richards;
展开▼
作者单位

展开▼
年(卷),期 -1(31),1
年度 -1
页码 241–244
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Lenalidomide Diffuse Large B-Cell Lymphoma rituximab;

机译：来那度胺;弥漫性大B细胞淋巴瘤;利妥昔单抗;

相似文献

外文文献
中文文献
专利

1. Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma [J] . Kumar Anita, Zelenetz Andrew D., Batlevi Connie Lee, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：序贯化疗和Lenalidomide的II期研究的初始结果，其次是Rituximab和Lenalidomide维持未处理的外壳细胞淋巴瘤
2. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium. [J] . Hainsworth JD, Flinn IW, Spigel DR, Clinical lymphoma, myeloma & leukemia . 2010,第1期

机译：短暂的利妥昔单抗/化学疗法，然后是维持性利妥昔单抗，用于弥散性大B细胞淋巴瘤且不适合R-CHOP化疗的患者：莎拉·坎农肿瘤研究联合会的II期试验。
3. Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study [J] . H. Hagberg, C. Gisselbrecht, and For the CORAL study group Annals of Oncology . 2006,第suppla4期

机译：R-ICE与R-DHAP在CD20弥漫性大B细胞淋巴瘤（DLBCL）复发患者中进行的III期随机研究，随后为大剂量治疗，以及是否随机给予利妥昔单抗维持治疗的第二次随机试验：CORAL研究的更新
4. Multispectral and phase-contrast diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study [C] . Xiaoping Liang, Qizhi Zhang, Stephen Staal, Optical tomography and spectroscopy of tissue VIII . 2009

机译：乳腺癌新辅助化疗过程中的多光谱和相差弥散光学层析成像：一个案例研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study [O] . Yan Zhang, Xiao Zhang, Dongmei Zou, 2021

机译：Lenalidomide和Rituximab方案结合玻璃体甲氨蝶呤其次是原发性培养物淋巴瘤的Lenalidomide维持：前瞻性二期研究
7. A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma [O] . N M Reddy, J P Greer, D S Morgan, 2016

机译：Lenalidomide或Lenalidomide和Rituximab的II期随机研究作为高/高中风险扩散大B细胞淋巴瘤的标准化疗后的维护治疗

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffuse Large B-Cell Lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅